Target intelligence / Profile preview

Prickle planar cell polarity protein 2 (PRICKLE2)

Target
PRICKLE2
Molecular classification
Other (planar cell polarity/signaling adaptor protein), Cytoskeletal-associated protein
01

Overview

Prickle planar cell polarity protein 2 (PRICKLE2) is a cytoplasmic signaling and scaffold protein critical for neuronal development, where it regulates planar cell polarity and microtubule bundling, particularly at the axon initial segment (AIS) in the brain[1][2]. PRICKLE2 is essential for correct synaptic development, proper post-synaptic density organization, and the maturation of axonal structures[1][2][3]. Mutations or loss of function in PRICKLE2 disrupts neuronal morphology, reduces dendritic branching and synaptic density, and is causally linked to progressive myoclonic epilepsy type 5 as well as autism spectrum disorder–like behaviors and neurodevelopmental deficits[3]. PRICKLE2 does not act as a classical drug target such as a receptor or enzyme; there are no known pharmacological modulators or interacting drugs[3]. Its main significance is as a regulatory node in neuronal polarity maintenance and central nervous system cytoarchitecture[1][2][3].

Other names
Prickle-like protein 2DKFZp686D143EPM5Prickle homolog 2PRICKLE2
02

Mechanism of action

Not applicable; no drugs specifically target PRICKLE2 as a therapeutic mechanism

03

Biological functions

Regulation of planar cell polarityMicrotubule bundling and cytoskeletal organizationRegulation of axon number and axon initial segment (AIS) maturationRegulation of synaptic developmentModulation of postsynaptic densityRole in non-canonical Wnt signaling
04

Disease associations

Neurodevelopmental disorderEpilepsy (progressive myoclonic epilepsy type 5)Autism spectrum disorder–like phenotypesOther (no major cancer or cardiovascular roles identified)
05

Safety considerations

Loss of function associated with developmental delay, epilepsy, and autistic features, suggesting risks to neurodevelopment if modulated
06

Interacting drugs

None identified
07

Biomarkers

None specifically established for patient selection or drug monitoring

Beyond the preview

Go deeper on Prickle planar cell polarity protein 2 (PRICKLE2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prickle planar cell polarity protein 2 (PRICKLE2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call